These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25018108)

  • 21. Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis.
    Kwok JB; Li QX; Hallupp M; Whyte S; Ames D; Beyreuther K; Masters CL; Schofield PR
    Ann Neurol; 2000 Feb; 47(2):249-53. PubMed ID: 10665499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies.
    Chen WT; Hong CJ; Lin YT; Chang WH; Huang HT; Liao JY; Chang YJ; Hsieh YF; Cheng CY; Liu HC; Chen YR; Cheng IH
    PLoS One; 2012; 7(4):e35807. PubMed ID: 22558227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation.
    Guardia-Laguarta C; Pera M; Clarimón J; Molinuevo JL; Sánchez-Valle R; Lladó A; Coma M; Gómez-Isla T; Blesa R; Ferrer I; Lleó A
    J Neuropathol Exp Neurol; 2010 Jan; 69(1):53-9. PubMed ID: 20010303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia.
    Tomiyama T; Nagata T; Shimada H; Teraoka R; Fukushima A; Kanemitsu H; Takuma H; Kuwano R; Imagawa M; Ataka S; Wada Y; Yoshioka E; Nishizaki T; Watanabe Y; Mori H
    Ann Neurol; 2008 Mar; 63(3):377-87. PubMed ID: 18300294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
    Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
    Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells.
    Fang B; Jia L; Jia J
    Neurosci Lett; 2006 Oct; 406(1-2):33-7. PubMed ID: 16916581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease.
    Golde TE; Cai XD; Shoji M; Younkin SG
    Ann N Y Acad Sci; 1993 Sep; 695():103-8. PubMed ID: 8239266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice.
    Wirths O; Multhaup G; Czech C; Feldmann N; Blanchard V; Tremp G; Beyreuther K; Pradier L; Bayer TA
    Brain Pathol; 2002 Jul; 12(3):275-86. PubMed ID: 12146796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The
    Pagnon de la Vega M; Giedraitis V; Michno W; Kilander L; Güner G; Zielinski M; Löwenmark M; Brundin R; Danfors T; Söderberg L; Alafuzoff I; Nilsson LNG; Erlandsson A; Willbold D; Müller SA; Schröder GF; Hanrieder J; Lichtenthaler SF; Lannfelt L; Sehlin D; Ingelsson M
    Sci Transl Med; 2021 Aug; 13(606):. PubMed ID: 34380771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.
    Maloney JA; Bainbridge T; Gustafson A; Zhang S; Kyauk R; Steiner P; van der Brug M; Liu Y; Ernst JA; Watts RJ; Atwal JK
    J Biol Chem; 2014 Nov; 289(45):30990-1000. PubMed ID: 25253696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress of Brain Amyloid Deposition in Familial Alzheimer's Disease with Taiwan D678H APP Mutation.
    Weng YC; Hsiao IT; Huang CY; Huang KL; Liu CH; Chang TY; Yen TC; Lin KJ; Huang CC
    J Alzheimers Dis; 2018; 66(2):775-787. PubMed ID: 30320594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
    Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants.
    Gorman PM; Kim S; Guo M; Melnyk RA; McLaurin J; Fraser PE; Bowie JU; Chakrabartty A
    BMC Neurosci; 2008 Jan; 9():17. PubMed ID: 18234110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway.
    Haass C; Lemere CA; Capell A; Citron M; Seubert P; Schenk D; Lannfelt L; Selkoe DJ
    Nat Med; 1995 Dec; 1(12):1291-6. PubMed ID: 7489411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomics of Alzheimer Disease: A Review.
    Rosenberg RN; Lambracht-Washington D; Yu G; Xia W
    JAMA Neurol; 2016 Jul; 73(7):867-74. PubMed ID: 27135718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characterization of an APP mutation (V717I) in five Han Chinese families with early-onset Alzheimer's disease.
    Zhang G; Xie Y; Wang W; Feng X; Jia J
    J Neurol Sci; 2017 Jan; 372():379-386. PubMed ID: 27838006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
    Kimura A; Hata S; Suzuki T
    J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.